5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to ProfitThe Motley Fool • 06/12/19
Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster HeadacheZacks Investment Research • 06/07/19
The Celgene Merger Looks Secure — So Why Is Bristol Under Pressure?Investors Business Daily • 06/05/19
Bristol-Myers Squibb And AbbVie: Pharma Dividend Opportunities With Large Margins Of SafetySeeking Alpha • 06/05/19
Bristol-Myers Squibb (BMY) Stock Moves -1.11%: What You Should KnowZacks Investment Research • 05/31/19